Cocaine and benzodiazepines are pharmacological opposites (one is a powerful central nervous system stimulant, the other a sedative) yet they are often used together. Some people who use cocaine take benzodiazepines to take the edge off the intense come-down, manage cocaine-induced anxiety, or help themselves sleep after a binge. What may seem like a practical workaround creates serious dangers: dual dependence, cognitive impairment, unpredictable overdose risk, and a treatment picture that is considerably more complex than addressing either substance alone.
This article explains what benzodiazepines are, why people combine them with cocaine, what happens physiologically when the two interact, the specific health risks, and what the research says about treating co-occurring cocaine and benzodiazepine use.
What Are Benzodiazepines?
Benzodiazepines, commonly called “benzos”, are a class of prescription medications that slow the central nervous system. They enhance the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, producing sedation, muscle relaxation, and anxiety relief. Common benzodiazepines include diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin).
Physicians prescribe benzodiazepines for anxiety disorders, panic disorder, alcohol withdrawal, seizures, and short-term insomnia. They are effective for these purposes when used as directed and for limited periods. However, physical dependence can develop quickly, sometimes within weeks, and misuse is common. According to a systematic review published in Drug and Alcohol Dependence, approximately 2.3% to 18% of Americans have misused sedatives or tranquilizers at some point in their lives.
Benzodiazepines are classified as Schedule IV controlled substances under the Controlled Substances Act, a lower scheduling than cocaine (Schedule II), but that designation can create a misleading sense of safety, particularly for people who are already using other substances.
Why Do People Combine Cocaine and Benzodiazepines?
The pairing is not accidental. People who use cocaine often experience specific discomforts that benzodiazepines appear to address. Research published in Drug and Alcohol Dependence identifies several motivations:
A study of multidrug users in South Florida’s nightclub scene found that heavy cocaine use (OR 2.27) was one of the strongest predictors of benzodiazepine dependence, more than doubling the odds compared to those without heavy cocaine use.
What Happens When Cocaine and Benzodiazepines Interact in the Body?
Cocaine is a stimulant that blocks the reuptake of dopamine, norepinephrine, and serotonin, flooding the brain with these neurotransmitters and producing euphoria, elevated heart rate, and heightened alertness. Benzodiazepines produce the opposite effects: they increase inhibitory neurotransmission through the GABA system, slowing brain activity, reducing anxiety, and lowering blood pressure.
When taken together, the two substances do not simply cancel each other out. The cocaine’s stimulant effects can mask how much sedation the benzodiazepine is actually producing. This masking effect means a person may take more of one or both substances than they realize, not accurately perceiving how impaired they are. The body is simultaneously trying to speed up (via cocaine’s norepinephrine effects on the heart) and slow down (via the benzo’s sedative action), placing major stress on the cardiovascular system.
The interaction also affects neurochemistry in ways that compound dependence risk. Cocaine’s dopaminergic activity and benzodiazepines’ GABA-mediated sedation create two separate, powerful reinforcement loops. Over time, the brain can adapt to both, making it harder for a person to feel normal, let alone well, without using both substances.
Health Risks of Combined Use
Overdose Risk
While the most publicized overdose risks involve opioids combined with benzodiazepines, stimulant-benzo combinations also carry significant risk. A review published in PMC on benzodiazepine epidemiology notes that co-ingesting benzodiazepines with other substances is consistently associated with increased overdose risk, particularly when multiple CNS-active substances are involved. The stimulant effects of cocaine can obscure signs of over-sedation until a medical emergency occurs.
Cardiovascular Stress
Cocaine already strains the cardiovascular system: raising heart rate, increasing blood pressure, and constricting blood vessels. Adding a benzodiazepine creates physiological conflict: the heart is being driven faster by cocaine while blood pressure dynamics are being altered by the sedative. An emergency room study of cocaine-positive patients found that co-use with benzodiazepines was not uncommon and noted that emergency physicians must systematically assess for multiple substances in cocaine-positive cases.
Cognitive Impairment
Both cocaine and benzodiazepines independently impair memory and executive function: cocaine through its effects on the prefrontal cortex, and benzodiazepines through GABA-mediated suppression of neural activity. Together, they can produce pronounced cognitive deficits. Research in populations who inject drugs has documented that benzodiazepines made people “not too conscious about risk,” contributing to unsafe injection practices and risky sexual behaviors.
Dual Dependence
Perhaps the most clinically significant risk is the development of simultaneous physical dependence on two very different substances. Cocaine dependence is primarily driven by psychological craving and dopamine dysregulation. Benzodiazepine dependence involves physical withdrawal, including the risk of seizures, that can be life-threatening if not managed medically. A person who is dependent on both faces withdrawal from two distinct physiological processes at the same time.
A review of benzodiazepine use and misuse found that approximately 40% of benzodiazepine abusers report a co-occurring psychiatric disorder. Clinicians should also assess and address mental health alongside both substance use disorders.
Patterns and Prevalence
Polysubstance use involving cocaine and benzodiazepines is not rare. A large cross-sectional study of 28,526 people entering substance use treatment found that benzodiazepines were among the most commonly co-used substances across treatment-seeking populations with cocaine as a primary substance. Co-use was associated with higher rates of anxiety, depression, PTSD, and unstable housing.
Emergency department data from a Spanish cohort study found that 72% of cocaine-positive patients also tested positive for another substance, with ethanol being most common, followed by cannabis and benzodiazepines.
Young adults in nightlife or electronic dance music settings represent a particularly high-risk group. A study of 521 multidrug users in South Florida found BZ dependence rates of 7.9%, with abuse and/or dependence reaching 25%, far above general population estimates.
Treatment Complexity: Addressing Both Substances
Treating co-occurring cocaine use disorder and benzodiazepine use disorder is clinically challenging. Each substance has its own withdrawal timeline and physiological mechanism, and the evidence-based treatment approaches don’t always align.
Benzodiazepine withdrawal can be medically dangerous, producing anxiety, insomnia, tremors, and in severe cases, seizures. Medical supervision and a structured taper, often using longer-acting benzodiazepines such as diazepam, is the standard approach. Attempting to stop benzodiazepines abruptly is not recommended and can be life-threatening.
Cocaine withdrawal, by contrast, is not typically medically dangerous in the acute phase but involves intense psychological symptoms: depression, fatigue, strong cravings, and anhedonia (the inability to feel pleasure). There are currently no FDA-approved medications specifically for cocaine use disorder, though contingency management and cognitive behavioral therapy (CBT) have strong evidence bases, as documented by NIDA’s research on cocaine treatment.
When both disorders co-exist, the treatment timeline is further complicated by the need to safely manage benzodiazepine withdrawal before or alongside cocaine treatment. The co-occurring psychiatric symptoms (anxiety, depression, PTSD) that often underlie polysubstance use also require concurrent attention. Integrated treatment programs that address all of these dimensions together typically produce better outcomes than sequential or siloed approaches.
Professional Perspective
The clinical literature on cocaine and benzodiazepines points to a pattern that is often underdiagnosed in treatment intake: as polysubstance use becomes more entrenched, benzodiazepine misuse becomes more likely, not less. The two reinforce each other. Benzodiazepines blunt the discomfort cocaine creates, cocaine offsets the dulling effect of chronic benzodiazepine use, and a person can become dependent on both without ever identifying either as the “primary” problem. A 2019 systematic review in Drug and Alcohol Dependence makes the broader pattern explicit:
“Benzodiazepine misuse increases with the overall level of polysubstance use.”
For people seeking help with cocaine use, this matters at the intake stage. A treatment plan built around cocaine alone, without identifying co-occurring benzodiazepine dependence, can miss the substance whose withdrawal is medically dangerous and whose continued use will undermine recovery from the other. Finding a program that screens thoroughly and treats both substances together is critical for combined cocaine and benzodiazepine use.
Combined cocaine and benzodiazepine use raises the bar for what counts as adequate treatment. The right program needs medical capacity to manage benzodiazepine tapering safely (abrupt cessation can produce seizures) and behavioral treatment with a track record for cocaine use disorder (contingency management and CBT have the strongest evidence). It also needs clinical attention to whatever underlies the polysubstance pattern in the first place, most often anxiety, depression, PTSD, or sleep disorders that have gone untreated.
When evaluating a program, ask directly: do they assess for benzodiazepine use at intake, even when cocaine is the stated reason for seeking help? Do they offer medically supervised tapering, or do they refer it out? And how do they handle the co-occurring mental health symptoms that almost always sit underneath this pattern of use? Programs that can answer all three clearly are the ones equipped to interrupt the cycle. Programs that focus on the cocaine and treat benzodiazepine use as a secondary issue risk leaving the person in a more dangerous withdrawal than they came in with.